Table 2.
Biochemical and biomarker values
| Study population (n=257) | |
|---|---|
| Lactate (mmol/L) | 1·5 (1·1–2·2), 223 |
| Creatinine (mg/dL) | 1·5 (0·9–2·4) |
| Proteinuria | 189/218 (87%) |
| Urine protein concentration (mg/dL) | 100 (30–300) |
| White blood cell count (×103 cells per μL) | 9·8 (6·6–12·7) |
| Lymphocyte count (×103 cells per μL) | 0·8 (0·6–1·2), 228 |
| Platelet count (×103 cells per μL) | 199 (148–270) |
| Bilirubin (mg/dL) | 0·6 (0·4–0·8), 242 |
| Aspartate aminotransferase (U/L) | 61 (42–104), 242 |
| Alanine aminotransferase (U/L) | 39 (27–67), 242 |
| Creatine kinase (U/L) | 236 (103–646), 223 |
| Prothrombin time (s) | 14·7 (14·0–15·8), 241 |
| Interleukin-6 (pg/mL) | 26 (11–69), 237 |
| High-sensitivity C-reactive protein (mg/L) | 158 (92–254), 253 |
| Ferritin (ng/mL) | 924 (472–1789), 253 |
| D-dimer (μg/mL) | 1·6 (0·9–3·5), 244 |
| High-sensitivity cardiac troponin T (ng/L) | 19 (9–52), 254 |
| Procalcitonin (ng/mL) | 0·35 (0·17–1·1), 255 |
Data are median (IQR) or n (%). Data are median (IQR), n if fewer patients were assessed for those laboratory studies than the total number of patients in the study.